AU2003217439A1 - Novel crystalline forms of finasteride - Google Patents
Novel crystalline forms of finasterideInfo
- Publication number
- AU2003217439A1 AU2003217439A1 AU2003217439A AU2003217439A AU2003217439A1 AU 2003217439 A1 AU2003217439 A1 AU 2003217439A1 AU 2003217439 A AU2003217439 A AU 2003217439A AU 2003217439 A AU2003217439 A AU 2003217439A AU 2003217439 A1 AU2003217439 A1 AU 2003217439A1
- Authority
- AU
- Australia
- Prior art keywords
- finasteride
- crystalline forms
- novel crystalline
- novel
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2003/000060 WO2004083230A1 (en) | 2003-03-19 | 2003-03-19 | Novel crystalline forms of finasteride |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003217439A1 true AU2003217439A1 (en) | 2004-10-11 |
Family
ID=33017816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003217439A Abandoned AU2003217439A1 (en) | 2003-03-19 | 2003-03-19 | Novel crystalline forms of finasteride |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003217439A1 (en) |
WO (1) | WO2004083230A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468860A (en) * | 1992-11-19 | 1995-11-21 | Merck & Co., Inc. | New finasteride processes |
US5652363A (en) * | 1995-10-05 | 1997-07-29 | C.D. Searle & Co. | Pyrido-1,4-oxazinylalkyl-benzamide derivatives |
-
2003
- 2003-03-19 WO PCT/IN2003/000060 patent/WO2004083230A1/en not_active Application Discontinuation
- 2003-03-19 AU AU2003217439A patent/AU2003217439A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004083230A1 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003202924A1 (en) | Variation of neural-stimulation parameters | |
AU2003230192A1 (en) | Novel crystalline forms of aripiprazole | |
AU2003239644A1 (en) | Crystallization of sugars | |
WO2005062897A3 (en) | Polymorphs of ezetimibe and processes for the preparation thereof | |
AP1955A (en) | Novel crystalline modification of the anhydrate ofboscalid | |
AU2003206803A1 (en) | Production of alkenones | |
AU2003268687A1 (en) | Novel salt of 2-acylaminothiazole derivative | |
AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
AU2003302372A1 (en) | Formulations of finasteride | |
AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
IL166592A0 (en) | Novel crystalline forms of gatifloxacin | |
AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
IL165115A0 (en) | Novel crystalline forms of gatifloxacin | |
AU2003224781A1 (en) | Crystalline forms of rabeprazole sodium | |
AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
AU2003217437A1 (en) | Novel crystalline forms of lamotrigine | |
AU2003257541A1 (en) | Novel crystals | |
AU2003217439A1 (en) | Novel crystalline forms of finasteride | |
IL165690A0 (en) | Novel crystalline forms of gatifloxacin | |
AU2003264861A1 (en) | Novel crystalline forms of celecoxib | |
EP1486485A4 (en) | Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative | |
AU2003238668A1 (en) | Novel crystalline forms of valdecoxib |